molecular glue degraders

Actionable Insights Powered by AI

Eisai Partners with SEED Therapeutics for $1.5 Billion Biobucks Deal in Neurodegeneration and Oncology

Eisai, SEED Therapeutics, biobucks deal, neurodegeneration, oncology, molecular glue degraders